Aa Aa Aa

Background color


Site version

Color Black and white

Calcium gluconate-Darnitsa

Calcium gluconate (stabilised) is a product that regulates metabolic processes, replenishes calcium deficiency, has a haemostatic, anti-allergic action and reduces capillary permeability. Calcium ions are involved in nerve impulse transmission, smooth and skeletal muscle contraction, myocardial functioning, blood clotting processes; they are required for bone tissue formation, and normal functioning of other systems and organs.

Hypoparathyroidism; increased calcium excretion from the body (especially during prolonged dehydration); as an adjuvant treatment in allergic diseases (serum sickness, urticaria, angioedema) and allergic complications of drug therapy; to reduce vascular permeability in pathological processes of any genesis (exudative phase of the inflammatory process, haemorrhagic vasculitis, radiation sickness); parenchymal hepatitis; toxic liver damage; nephritis; eclampsia; hyperkalemia; hyperkalemic paroxysmal myoplegia; skin diseases (pruritis, eczema, psoriasis); as a haemostatic agent; as an antidote in poisoning with magnesium salts, oxalic acid or its soluble salts, soluble fluoric acid salts.

Administer intravenously or intramuscularly.

Prior to administration, bring the ampoule with the solution to body temperature. Inject the solution slowly, over 2–3 minutes.

For adults and children of 14 years of age and over, administer 5 to 10 ml of Calcium Gluconate-Darnitsa (stabilised) daily or every 1–2 days, depending on the disease course and the patient's condition.

In children intravenously only, administer 10% solution of calcium gluconate at the following doses depending on age: under 6 months — 0.1–1 ml, 6–12 months — 1–1.5 ml, 1–3 years — 1.5 –2 ml, 4–6 years — 2–2.5 ml, 7–14 years — 3–5 ml.

For the administration of less than 1 ml of solution, adjust a single medicine dose to an appropriate volume (syringe volume) with 0.9% sodium chloride solution or 5% glucose solution.


The medicine is not recommended for intramuscular administration in children under the age of 14 due to the possibility of necrosis.

Specialized edition for medical institutions and doctors.